Thu, 10/27/2022 - 11:00
The MAB will help STO maximize its global impact and improve equitable patient access to safe, effective, and affordable innovative new medicines.
Tue, 10/18/2022 - 09:00
STO is pleased to announce the addition of Drs. Sean Khozin, Ke Liu, Mace L. Rothenberg, and Lillian L. Siu to its Board of Directors.
Privacy Policy | Terms of Use | Contact Us
Society for Translational Oncology (STO) is a 501(c)(3) not-for-profit organization.
Copyright © 2023. All rights reserved.